Video: Roberto Soto, MD, discusses his experience with PET imaging with Amyvid for Alzheimer’s evaluation, including reimbursement, training, and benefits of the new test.
SPECT/MR debuted this week at the SNMMI annual meeting as a new preclinical hybrid molecular imaging system with promises of higher resolution and lower dose.
CMS is allowing local contractors to determine coverage of new oncology PET tracers, but tracers for neurological or cardiac uses aren’t included in the change.
Video: Roberto Soto, MD, discusses his experience with PET imaging with Amyvid for Alzheimer’s evaluation, including reimbursement, training, and benefits of the new test.
Osman Ratib, MD, PhD, FAHA, professor and chief of nuclear medicine in the Department of Radiology at the University Hospital of Geneva, discusses the advantages and future of the hybrid PET/MR modality.
